Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. 2. Tadalafil analogs
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. 2. Tadalafil analogs
Date
2012-02-02
Authors
Ochiana, Stefan O.
Gustafson, Alden
Bland, Nicholas D.
Wang, Cuihua
Russo, Michael J.
Campbell, Robert K.
Pollastri, Michael P.
Gustafson, Alden
Bland, Nicholas D.
Wang, Cuihua
Russo, Michael J.
Campbell, Robert K.
Pollastri, Michael P.
Linked Authors
Person
Person
Person
Person
Person
Alternative Title
Citable URI
As Published
Date Created
Location
DOI
Related Materials
Replaces
Replaced By
Keywords
Neglected disease
Trypanosoma brucei
Target repurposing
Phosphodiesterase inhibitors
TbrPDEB1
PDE5
Tadalafil
Trypanosoma brucei
Target repurposing
Phosphodiesterase inhibitors
TbrPDEB1
PDE5
Tadalafil
Abstract
In this report we describe our ongoing target repurposing efforts focused on discovery of inhibitors of the essential trypanosomal phosphodiesterase TbrPDEB1. This enzyme has been implicated in virulence of Trypanosoma brucei, the causative agent of human African trypanosomiasis (HAT). We outline the synthesis and biological evaluation of analogs of tadalafil, a human PDE5 inhibitor currently utilized for treatment of erectile dysfunction, and report that these analogs are weak inhibitors of TbrPDEB1.
Description
Author Posting. © The Author(s), 2012. This is the author's version of the work. It is posted here by permission of Elsevier B.V. for personal use, not for redistribution. The definitive version was published in Bioorganic & Medicinal Chemistry Letters 22 (2012): 2582-2584, doi:10.1016/j.bmcl.2012.01.118.